Ivabradine


- TRADE NAMES: Corlanor (Amgen); Procoralan (Servier)
- INDICATIONS: Chronic stable angina pectoris
- CLASS: Cardiotonic agent, HCN channel blocker
- HALF-LIFE: 2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Azole antifungals, Clarithromycin, CYP3A4 inducers, Diltiazem, Grapefruit Juice, Itraconazole, Ketoconazole, Macrolide antibiotics, Nefazodone, Nelfinavir, Pentamidine, Phenytoin, Rifampin, Ritonavir, Sotalol, St John's Wort, Strong or moderate CYP3A4 inhibitors, Telithromycin, Verapamil
PREGNANCY CATEGORY: N/A
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of ivabradine in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric